Sumitomo Pharma Co Ltd
XBER:DPM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sumitomo Pharma Co Ltd
XBER:DPM
|
JP |
|
Kasumigaseki Capital Co Ltd
F:H0A
|
JP |
|
Hydro One Ltd
TSX:H
|
CA |
|
T
|
Titan International Inc
F:TZ4
|
US |
|
E
|
Eris Lifesciences Ltd
BSE:540596
|
IN |
|
Carel Industries SpA
F:CIG
|
IT |
Wall St Price Targets
DPM Price Targets Summary
Sumitomo Pharma Co Ltd
According to Wall Street analysts, the average 1-year price target for DPM is 17.75 EUR with a low forecast of 12.65 EUR and a high forecast of 23.68 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DPM's stock price target?
Price Target
17.75
EUR
According to Wall Street analysts, the average 1-year price target for DPM is 17.75 EUR with a low forecast of 12.65 EUR and a high forecast of 23.68 EUR.
What is the Revenue forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
-26%
Over the last 13 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 2 years is -26%.
What is the Pre-Tax Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
84%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 84%.
What is the Net Income forecast for Sumitomo Pharma Co Ltd?
Projected CAGR
48%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 48%.
